TRAF4 and neoplasm: In this context, risperidone acts as a pharmacological inhibitor of TRAF4, effectively suppressing the self-renewal of glioblastoma (GBM), eradicating tumor pathogenicity, and reversing resistance to temozolomide (Li et al. 2022).